Business Standard

Roche seeking fast approval of antibody cocktail in India to treat Covid

Co says demand for tocilizumab may exceed supplies it can provide

Roche
Premium

Sohini Das Mumbai
Swiss giant Roche Pharma said on Wednesday that it is working with Indian authorities to accelerate the emergency-use authorisation (EUA) for its investigational antibody cocktail (Casirivimab and Imdevimab) in India. 

It is seeking an EUA in India based on the data filed for getting the EUA in the US and also scientific opinion of the Committee for Medicinal Products for Human Use (CHMP) in the EU. Once it gets an EUA here, it can import the globally manufactured product batches to India as soon as possible, the company said. 

It added that it is also trying to expand production of tocilizumab (brand

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 28 2021 | 7:19 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com